Causes of Fatigue in Haemochromatosis
Fatigue in haemochromatosis is primarily caused by iron toxicity from progressive iron accumulation in organs, and it correlates directly with the degree of liver iron overload. 1
Primary Mechanism: Iron Toxicity
The fundamental cause of fatigue is iron-mediated organ damage resulting from the disease's core pathophysiology 2:
- Increased intestinal iron absorption and iron release from macrophages leads to an expanded circulating iron pool
- Progressive iron accumulation occurs mainly in the liver, but also affects the heart, pancreas, and endocrine glands
- This iron deposition causes direct cellular toxicity and organ dysfunction
The prevalence of fatigue increases significantly as liver iron concentration rises, establishing a clear dose-response relationship between iron burden and symptom severity 1. This confirms that iron toxicity itself is the primary pathogenic mechanism for fatigue.
Clinical Context
Fatigue is one of the most common presenting symptoms across all age groups 1, 3:
- Fatigue appears as a presenting complaint in approximately 27-45% of patients at diagnosis
- It often manifests before more severe complications like cirrhosis, diabetes, or cardiac disease develop
- The symptom is nonspecific, contributing to diagnostic delays that can range from 1-15 years 3
Secondary Contributing Factors
Beyond direct iron toxicity, fatigue may be compounded by:
End-Organ Complications
- Diabetes mellitus - from pancreatic iron deposition
- Cardiac disease - from myocardial iron accumulation
- Hypogonadotrophic hypogonadism - particularly in severe or early-onset cases 2
- Hypothyroidism - in advanced disease
- Cirrhosis - representing advanced hepatic iron overload
Associated Conditions
- Arthropathy - joint manifestations frequently co-occur with fatigue 3, 4
- Anxiety and psychological burden - from chronic disease and genetic implications 4
Critical Diagnostic Consideration
If fatigue persists despite adequate iron depletion therapy (phlebotomy), a complete workup for alternative causes must be performed 2. This is essential because:
- Fatigue should improve with successful iron removal
- Persistent symptoms suggest either inadequate treatment or an alternative diagnosis
- Hyperferritinemia has many causes beyond haemochromatosis, and the wrong diagnosis may have been made initially
Treatment Implications
Recent evidence suggests that erythrocytapheresis may reduce fatigue more effectively than phlebotomy in some patients 2, though both modalities work by removing excess iron and reducing organ toxicity. The key is achieving target ferritin levels (<50 μg/L during induction, 50-100 μg/L during maintenance) to reverse iron-mediated damage.
The relationship between iron burden and fatigue underscores why early diagnosis and treatment are critical - they can prevent the organ damage that causes this debilitating symptom 2, 1.